Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma
Rhabdomyosarcomas are tumours blocked in myogenic differentiation, which despite the expression of master muscle regulatory factors, including MYOD, are unable to differentiate. Here, the authors show that SNAI2 is upregulated by MYOD through super enhancers, binds to MYOD target enhancers, and arre...
Main Authors: | Silvia Pomella, Prethish Sreenivas, Berkley E. Gryder, Long Wang, David Milewski, Matteo Cassandri, Kunal Baxi, Nicole R. Hensch, Elena Carcarino, Young Song, Hsien-Chao Chou, Marielle E. Yohe, Benjamin Z. Stanton, Bruno Amadio, Ignazio Caruana, Cristiano De Stefanis, Rita De Vito, Franco Locatelli, Yidong Chen, Eleanor Y. Chen, Peter Houghton, Javed Khan, Rossella Rota, Myron S. Ignatius |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-20386-8 |
Similar Items
-
FAK Signaling in Rhabdomyosarcoma
by: Clara Perrone, et al.
Published: (2020-11-01) -
Disruption of the MyoD/p21 Pathway
in Rhabdomyosarcoma
by: Michael Weintraub, et al.
Published: (1997-01-01) -
Deletion of Snai2 and Snai3 results in impaired physical development compounded by lymphocyte deficiency.
by: Peter D Pioli, et al.
Published: (2013-01-01) -
SNAI1 and SNAI2 are asymmetrically expressed at the 2-cell stage and become segregated to the TE in the mouse blastocyst.
by: Christine E Bell, et al.
Published: (2009-12-01) -
CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG
by: Zhihui Liu, et al.
Published: (2020-02-01)